Location History:
- Cambridge, MA (US) (2014)
- Boston, MA (US) (2017)
Company Filing History:
Years Active: 2014-2017
Title: Innovations by Sutheera Ratanasirintrawoot: Advancements in Human Somatic Cell Reprogramming
Introduction
Sutheera Ratanasirintrawoot is a prominent inventor based in Boston, MA, who has made significant contributions to the field of biomedical research. Known for his innovative approaches, Ratanasirintrawoot holds two patents related to the detection and monitoring of human somatic cell reprogramming, which have important implications for regenerative medicine.
Latest Patents
Ratanasirintrawoot's latest patents focus on the detection of human somatic cell reprogramming. The methods and kits developed are based on his discovery of a phenotype that represents a fully-reprogrammed induced pluripotent stem (iPS) cell, along with several reprogramming intermediates. These methods allow for the identification and monitoring of fully-reprogrammed iPS cells during the reprogramming process. Notably, the techniques can be performed in real-time using live cell imaging. Furthermore, the patents provide methods for screening candidate reprogramming agents by examining the emergence of fully-reprogrammed iPS cells in both the presence and absence of such agents.
Career Highlights
Sutheera Ratanasirintrawoot works at the Children's Medical Center Corporation, a leading institution in pediatric healthcare and research. His work there has been instrumental in advancing the understanding and application of iPS technology in medical treatments. Over the years, Ratanasirintrawoot has continually pushed the boundaries of what is possible in the arena of cellular reprogramming and regenerative medicine.
Collaborations
Throughout his career, Ratanasirintrawoot has collaborated with esteemed colleagues such as George Q. Daley and In-Hyun Park. These collaborations have fostered innovative research initiatives and helped to propel significant advancements in the understanding of stem cell biology and regenerative techniques.
Conclusion
Sutheera Ratanasirintrawoot stands out as an influential figure in the realm of innovations related to human somatic cell reprogramming. His patented methodologies and ongoing research contribute greatly to the broader scientific community, promising future breakthroughs in regenerative medicine. As the field continues to evolve, Ratanasirintrawoot's work will undoubtedly remain at the forefront of innovation in biotechnology.